EE209 Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment in Adult Patients Following Complete Resection and Platinum-Based Chemotherapy with Non-Small Cell Lung Cancer (NSCLC) in Finland
Abstract
Authors
T Männik N Jovanoski M Vuojolainen A Knuuttila A Jekunen J Laine